🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

16 recruiting trials

for Advanced EGFR Positive Solid Tumor

Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors NCT06960395Phase 14 sites📍 Scottsdale📍 Houston📍 Wollongong Vir Biotechnology, Inc. · Tests: VIR-5525, Pembrolizumab ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies NCT04412616Phase 15 sites📍 Los Angeles📍 Fairway📍 The Bronx Changchun Intellicrown Pharmaceutical Co. LTD · Tests: ZZ06 Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites📍 Phoenix📍 Tucson📍 Los Angeles Genmab · Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin HEAT Trial (HER2 Antibody Therapy With Lutetium-177) NCT06824155EARLY Phase 15 sites📍 Kingswood📍 Macquarie Park📍 Wollongong Radiopharm Theranostics, Ltd · Tests: 177Lu-RAD202 Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer NCT07137416Phase 12 sites📍 Boston📍 St Louis National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Echocardiography Test, Multigated Acquisition Scan, Pidnarulex A Phase 1/1b Study of IAM1363 in HER2 Cancers NCT06253871Phase 153 sites📍 La Jolla📍 Los Angeles📍 Aurora Iambic Therapeutics, Inc · Tests: IAM1363 Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors NCT03740256Phase 11 site📍 Houston Baylor College of Medicine · Tests: CAdVEC Phase II Study of Becotatug Vedotin Plus Pucotenlimab for Advanced Refractory Solid Tumors With EGFR-Positive NCT07712029Phase 21 site📍 Tianjin Tianjin Medical University Second Hospital · Tests: Becotatug Vedotin, Pucotenlimab Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors NCT05985655Phase 1, Phase 215 sites📍 Los Angeles📍 Grand Rapids📍 New York Exscientia AI Ltd., a wholly owned subsidiary of Recursion … · Tests: GTAEXS617, SoC A Study of Almonertinib Combined With Palbociclib in Patients With Advanced Solid Tumors Harboring KRAS Mutations NCT06947811Phase 1, Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Almonertinib, Palbociclib HER-2 B Cell Peptide Vaccine NCT06414733Phase 11 site📍 Indianpolis Pravin T.P Kaumaya · Tests: Combination of MVF-HER-2 (597-626) and MVF-HER-2 (266-296) emulsified with ISA 51 A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors NCT05688605Phase 1, Phase 22 sites📍 Guangzhou📍 Changsha Lepu Biopharma Co., Ltd. · Tests: MRG003+HX008 A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer NCT04872166Phase 16 sites📍 Lake Mary📍 Sarasota📍 Cincinnati Edgewood Oncology Inc. · Tests: BTX-A51 APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors NCT03175224Phase 235 sites📍 Los Angeles📍 Tampa📍 Boston Apollomics Inc. · Tests: APL-101 Oral Capsules EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer NCT05341492EARLY Phase 11 site📍 Guangzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: EGFR/B7H3 CAR-T A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor NCT07612891Phase 1, Phase 21 site📍 Shanghai Shenzhen Ionova Life Sciences Co., Ltd. · Tests: INV-6452
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy